Showing results (71-80 of 131) with videos related to
Sort By:
Pageof 14
Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysisDorothy Romanus, Martin R Weiser, John M Skibber, et al.Cancer|May 1, 2012
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer NetworkNancy U Lin, Ann Vanderplas, Melissa E Hughes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancerMichael J Hassett, Melissa E Hughes, Joyce C Niland, et al.Urology|August 5, 2011
Adrenocortical carcinoma masquerading as a benign adenoma on computed tomography washout studyJay Simhan, Daniel Canter, Ervin Teper, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 26, 2024
Changes in Risk Tolerance for Ovarian Cancer Prevention Strategies during the COVID-19 Pandemic: Results of a Discrete Choice ExperimentBrian L Egleston, Mary B Daly, Kaitlyn Lew, et al.JAMA Oncology|December 15, 2015
Time to Surgery and Breast Cancer Survival in the United StatesRichard J Bleicher, Karen Ruth, Elin R Sigurdson, et al.Urology|August 17, 2010
Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomyDaniel Canter, Rosalia Viterbo, Alexander Kutikov, et al.The Journal of Urology|May 20, 2014
Care transitions between hospitals are associated with treatment delay for patients with muscle invasive bladder cancerJeffrey J Tomaszewski, Elizabeth Handorf, Anthony T Corcoran, et al.Journal of Oncology Practice|June 23, 2016
Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With CancerCaitlin R Meeker, Daniel M Geynisman, Brian L Egleston, et al.BJU International|November 20, 2009
Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomyAlexander Kutikov, Robert G Uzzo, Aaron Caraway, et al.Pageof 14